• VOD-new-1

PCCA News

Read about the latest news from PCCA and compounding.

Members-Only site now can be viewed easily on mobile devices such as smartphones and tablet computers.

A 51-year-old male received a third-degree burn on his back, neck and ear after being involved in an explosion. PracaSil™-Plus, a proprietary anhydrous silicone scar base, was applied three times per week to the affected area, which resulted in complete healing within 21 days.

LoxaSperse™ is a powder excipient base used for nasal nebulization and irrigation designed to improve dispersibility and solubility of Active Pharmaceutical Ingredients (APIs).

The efficacy of PracaSil-Plus in the improvement of scar appearance was evaluated by visual and instrumental methods in an eight-week, randomized, double-blind, controlled study.

PCCA Member Cheri Kraemer, RPh, of Sioux Falls, South Dakota, Recognized as a Female Advocate Who is Advancing the Compounding Industry in the Sioux Falls Community

PCCA Award Recognizes Female Advocates Who are Advancing the Compounding Pharmacy Industry in their Community

Progesterone is a hormonal steroid used as a lipophilic drug model for evaluation of the effect of two different excipients, LoxOral and lactose monohydrate, on in vitro sustained release drug from pharmaceutical compounded oral capsules.

PCCA Cream Bases Now Proven to Transport Progesterone Into and Through Human Skin Better Than Vanicream®

The two-day conference was entirely dedicated to bringing together the latest advances, challenges and opportunities for developing medicinal products and medicinal devices for pediatric use.

The FIP (International Pharmaceutical Federation) is a global federation representing three million pharmacists and pharmaceutical scientists worldwide.

Investments in staff and equipment requires larger space.

A 72-year-old caucasian male reported extreme pain, scaling, redness, and irritation on his burns resulting from multiple radiation treatments. He applied PracaSil™-Plus, a proprietary anhydrous silicone scar base, several times per day as needed to the lateral side of the face and neck which resulted in complete healing within 14 days.

The intent of this study was to evaluate results of purposeful inoculation of the formulations with microorganisms specified in USP <51> (The United States Pharmacopeial Convention, 2013a), for nasal and inhalation use with modified Antimicrobial Effectiveness Test (AET) methodology and to quantitatively determine the in vitro effectiveness of formulations containing LoxaSperse to prevent microbial proliferation and/or kill the organisms.

The intent of this study was to evaluate results of purposeful inoculation of the formulations with microorganisms specified in USP <51> (The United States Pharmacopeial Convention, 2013a), for nasal and inhalation use with modified Antimicrobial Effectiveness Test (AET) methodology and to quantitatively determine the in vitro effectiveness of formulations containing LoxaSperse to prevent microbial proliferation and/or kill the organisms.

Expands access to innovative custom-compounded personalized medicines

This Abstract Poster Presentation presented at 2014 PBMI Annual Drug Benefit Conference (3-5 Feb 2014) in Las Vegas, Nevada is a comprehensive review and appraisal of the literature on clinical efficacy of topical compounded products versus traditional therapy for the treatment of neuropathic, osteoarthritic, oncologic and other types of complex chronic pain syndromes.

A compounded medicine using PracaSil-Plus (PCCA Formula #10843) was applied topically in an open wound located on the leg of a diabetic patient, with outstanding healing results.

The purpose of this study was to evaluate the potential of LoxOral to enhance the dissolution properties of piroxicam and to evaluate its utility in comparison to MCC delivery systems.

The purpose of this study was to evaluate the potential of LoxOral to enhance the dissolution properties of ketoconazole and to evaluate its utility in comparison to MCC delivery systems.

A compounded medicine using PracaSil-Plus (PCCA Formula # 10843), was applied topically to the right and left elbow injuries caused by a fitness competition, which resulted in considerable healing progress.

Award presented annually to a young independent pharmacist who embodies Roentsch's innovative and sharing nature

Award presented annually to an independent pharmacist demonstrating service excellence to patients, healthcare providers and pharmacy colleagues.

The in vitro antimicrobial activity of itraconazole in a LoxaSperse formulation was evaluated against Candida albicans biofilms and compared to the same activity of reference antifungal drugs (itraconazole, fluconazole and amphotericin B), in order to verify the benefits of the LoxaSperse formulation.

PCCA tested the performance of PCCA Formula #10337 (gentamicin 80 mg/LoxaSperse), and measured its efficacy against microbial activity when mixed with sterile water.

PCCA tested the performance of PCCA Formula #10341 (budesonide 0.5 mg in a LoxaSperse mixture) and measured its efficacy against microbial activity when mixed with sterile water.

The physical and microbiological properties of LoxaSperse were characterized by three laboratory tests performed with LoxaSperse and LoxaSperse with itraconazole.

This Abstract Poster Presentation presented at PAINWeek 2013 (4 - 7 Sep 2013) in Las Vegas, Nevada deals with evaluation of the in vitro human trunk skin percutaneous absorption of Ketamine HCl, Gabapentin, Clonidine HCl and Baclofen using the Franz Skin Finite Dose Model

This Abstract Poster Presentation presented at the FIP World Congress Dublin, Ireland (31 Aug – 5 Sep 2013) deals with the complexities and opportunities presented through compounding for pediatric patients.

Summary: PracaSil-Plus, a proprietary anhydrous silicone base, was applied topically on an infant’s facial scalding burn and on a toddler’s diaper rash, resulting in considerable progress in both pediatric case studies.

Bruce Biundo named 2013 Pharmacist of the Year by the Texas Pharmacy Association (TPA)

The efficacy of PracaSil-Plus in scar therapy treatment was evaluated by visual and instrumental methods in an eight-week, randomized, double-blind, controlled study.

PracaSil-Plus, a proprietary anhydrous silicone base, was applied topically on ankle scars (old & new) and an overall improvement of both ankle scars was observed in a very short period of time.

PracaSil-Plus, a proprietary anhydrous silicone base, was applied topically on ankle scars (old & new) and an overall improvement of both ankle scars was observed in a very short period of time.

A compounded medicine containing PracaSil-Plus (PCCA Formula #10649) was applied topically on facial scars (old) and an overall improvement of the facial complexion was observed following only 3 weeks.

Lipoderm and Lipoderm ActiveMax Now Proven to Deliver Lorazepam Into and Through Human Skin

“Anyone who knows Lucy will attest to her passion and enthusiasm for her chosen profession of compounding pharmacy.”

New manufacturing vessel greatly increases PCCA's base production capacity.

Introducing a comprehensive line of unique dermatological products, exclusively for PCCA members. PCCA’s Research and Development team has developed these bases so you can help heal patients and become your prescribers’ favorite problem-solver.

It is with heavy hearts that we pass on the news that our beloved Kay Sparks, former PCCA Associate Director of Training/Director of Student Training, and wife of PCCA CEO L. David Sparks, passed away on December 25, 2012, at the age of 70.

Award presented annually to a young independent pharmacist who embodies Roentsch's innovative and sharing nature

Award presented annually to an independent pharmacist demonstrating service excellence to patients, healthcare providers and pharmacy colleagues.

Award presented annually to an independent pharmacist demonstrating service excellence to patients, healthcare providers and pharmacy colleagues.

PCCA's new East Coast Baltimore depot joins the West Coast Las Vegas depot and PCCA’s Houston home office to provide rapid delivery to all PCCA members across the United States!

Practitioners now have user-friendly alternative for patients taking multiple dosages

Award presented annually to a young independent pharmacist who embodies Roentsch's innovative and sharing nature

Award presented annually to an independent pharmacist demonstrating service excellence to patients, healthcare providers and pharmacy colleagues.

Pharmacists Are Often The Only Option For Vital Pediatric And Cancer Prescriptions

Lipoderm® Proven to Deliver Ketamine HCl, Gabapentin, Clonidine HCl and Baclofen Simultaneously Through Human Skin In Vitro – FIRST STUDY OF ITS KIND

Lipoderm with Tramadol Performs Well in Feline Inner Ear Test

PCCA Lipoderm now PROVEN to Deliver the NSAID Ketoprofen Through Human Skin In Vitro

Lipoderm Proven to Deliver Promethazine HCl Through Human Skin In Vitro